Revascularization in Patients With Severe Left Ventricular Dysfunction Is the Assessment of Viability Still Viable?

被引：42

作者：

Anavekar, Nandan S. ^{[1
]}

Chareonthaitawee, Panithaya ^{[2
]}

Narula, Jagat ^{[2
]}

Gersh, Bernard J. ^{[1
]}

机构：

[1] Mayo Clin, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA

[2] Icahn Sch Med Mt Sinai, Div Cardiovasc Dis, New York, NY 10029 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 24期

关键词：

coronary artery bypass graft; coronary artery disease; myocardial hibernation; myocardial ischemia; myocardial stunning; CORONARY-ARTERY-DISEASE; POSITRON-EMISSION-TOMOGRAPHY; MEDICALLY TREATED PATIENTS; LOW EJECTION FRACTION; ENHANCED MAGNETIC-RESONANCE; RANDOMIZED CONTROLLED-TRIAL; CONGESTIVE-HEART-FAILURE; MYOCARDIAL VIABILITY; HIBERNATING MYOCARDIUM; ISCHEMIC CARDIOMYOPATHY;

D O I：

10.1016/j.jacc.2016.03.571

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Myocardial viability assessment is typically reserved for patients with coronary artery disease and significant left ventricular dysfunction. In this setting, there is myocardial adaptation to an altered physiological state that is potentially reversible. Imaging can characterize different parameters of cardiac function; however, despite previously published appraisals of different imaging modalities, there is still uncertainty regarding the role of these tests in clinical practice. The purpose of this review is to reflect on the physiological basis of myocardial viability, discuss the imaging tests available that characterize myocardial viability, and summarize the current published reports on the use of these tests in clinical practice. (C) 2016 by the American College of Cardiology Foundation.

引用

页码：2874 / 2887

页数：14

共 84 条

[1] 18F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to 18F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial [J].

Abraham, Arun ;

Nichol, Graham ;

Williams, Kathryn A. ;

Guo, Ann ;

deKemp, Robert A. ;

Garrard, Linda ;

Davies, Ross A. ;

Duchesne, Lloyd ;

Haddad, Haissam ;

Chow, Benjamin ;

DaSilva, Jean ;

Beanlands, Rob S. B. .

JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (04) :567-574

[2] Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction [J].

Afridi, I ;

Grayburn, PA ;

Panza, JA ;

Oh, JK ;

Zoghbi, WA ;

Marwick, TH .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (04) :921-926

[3] 10-YEAR FOLLOW-UP OF SURVIVAL AND MYOCARDIAL-INFARCTION IN THE RANDOMIZED CORONARY-ARTERY SURGERY STUDY [J].

ALDERMAN, EL ;

BOURASSA, MG ;

COHEN, LS ;

DAVIS, KB ;

KAISER, GG ;

KILLIP, T ;

MOCK, MB ;

PETTINGER, M ;

ROBERTSON, TL .

CIRCULATION, 1990, 82 (05) :1629-1646

[4] RESULTS OF CORONARY-ARTERY SURGERY IN PATIENTS WITH POOR LEFT-VENTRICULAR FUNCTION (CASS) [J].

ALDERMAN, EL ;

FISHER, LD ;

LITWIN, P ;

KAISER, GC ;

MYERS, WO ;

MAYNARD, C ;

LEVINE, F ;

SCHLOSS, M .

CIRCULATION, 1983, 68 (04) :785-795

[5] Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis [J].

Allman, KC ;

Shaw, LJ ;

Hachamovitch, R ;

Udelson, JE .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1151-1158

[6] Noninvasive assessment myocardial viability: Current status and future directions [J].

Allman, Kevin C. .

JOURNAL OF NUCLEAR CARDIOLOGY, 2013, 20 (04) :618-637

[7]

ALTEHOEFER C, 1994, J NUCL MED, V35, P569

[8] Left ventricular dysfunction: causes, natural history, and hopes for reversal [J].

Armstrong, P .

HEART, 2000, 84 :I15-I17

[9] Radionuclide techniques for the assessment of myocardial viability and hibernation [J].

Bax, JJ ;

van der Wall, EE ;

Harbinson, M .

HEART, 2004, 90 :V26-V33

[10]

Bax JJ, 2001, CIRCULATION, V104, pI314

← 1 2 3 4 5 6 7 8 9 →